-
NYU Langone names new surgical oncology chief
New York City-based NYU Langone Health has named Gary Deutsch, MD, chief of the surgical oncology division at NYU Grossman Long Island School of Medicine. -
Fox Chase names chief of new breast surgery division
Fox Chase Cancer Center in Philadelphia has promoted Richard Bleicher, MD, to chief of the center's new breast surgery division. -
Cancer screening costs hit $43B in 2021: Study
The total U.S. healthcare system costs for initial cancer screenings in 2021 were an estimated $43 billion, according to a study published Aug. 5 in The Annals of Internal Medicine. -
Aspirin use associated with lower colon cancer risk
Aspirin use was associated with a lower risk of colon cancer for some patients, according to a study published Aug. 1 in JAMA Oncology. -
FDA approves 1st gene therapy for synovial sarcoma
The FDA has approved the gene therapy Tecelra for treatment of synovial sarcoma. -
US agency unveils POSEIDON to advance at-home cancer testing
A new project through the Advanced Research Projects Agency for Health, or ARPA-H, aims to create an at-home cancer screening test that can detect more than 30 types of Stage 1 cancers using breath or urine samples. -
Why MD Anderson is sending T-cells to space
Researchers at The University of Texas MD Anderson Cancer Center are sending T-cells to the International Space Station to investigate how microgravity affects the cells, which could lead to advancements in treatments for cancer and autoimmune diseases. -
Cancer care deserts are spreading
Cancer treatment deserts are growing as more rural hospitals close and cut services, CBS News reported Aug. 1. -
American Cancer Society finds Gen X, millennials at higher risk for 17 cancers
Gen Xers, born between 1965 and 1980, and millennials, born between 1981 and 1996, are at risk for 17 of the 34 existing cancer types, a new study from the American Cancer Society has revealed. -
2 cancer drugs receive FDA designations
The FDA has granted designations for cancer drug therapies addressing pancreatic cancer and melanoma. -
California cancer center director steps down
Ze’ev Ronai, PhD, is stepping down as director of San Diego, Calif.-based Sanford Burnham Prebys on Aug. 1. -
Good Samaritan opens free cancer rehab program
Kearney, Neb.-based CHI Health Good Samaritan opened a free cancer rehabilitation program, KGFW reported July 30. -
Top medication spend for oncology drugs
Oncology medications made up 24.14% of pharmacy program participants' drug spend from April 2023 to March 2024, according to Vizient's "Summer 2024 Pharmacy Market Outlook" report. -
UC Davis increases stage 1 lung cancer diagnosis by 49%
Sacramento, Calif.-based UC Davis Health is utilizing 3D imagery to detect lung cancer sooner. -
FDA approves blood test for colon cancer
The FDA has approved Guardant Health's Shield blood test for colon cancer screening. -
Mayo opens LGBTQ+ breast cancer center
Mayo Clinic-Rochester (Minn.) opened Rainbows Breast Cancer Clinic, a clinic for LGBTQ+ breast cancer patients, the Post Bulletin reported July 27. -
WVU Cancer Institute to open clinic for geriatric patients
The WVU Cancer Institute in Morgantown, W.Va., is set to open a new geriatric oncology clinic in August. -
U of Mississippi Medical Center joins precision oncology group
The University of Mississippi Medical Center in Jackson has joined the Caris Life Sciences' Precision Oncology Alliance network. -
No survival advantage for double mastectomies over other treatments, study suggests
Double mastectomies have similar survival rates to lumpectomies and single mastectomies, according to research published July 25 in JAMA Oncology. -
New combination therapy may improve leukemia survival rates: Study
A newly tested combination therapy showed a higher rate of survival compared to chemotherapy alone, according to a study published July 24 in The New England Journal of Medicine.
Page 9 of 50